The weight-loss drug trend sweeping the nation could be coming for your furry friends.
Okava Pharmaceuticals, a biopharmaceutical company based in San Francisco, is expected to announce on Tuesday that it has launched a pilot study testing a GLP-1 drug in obese cats, the New York Times reports.